Pricing Log in Create free account

Advanced Biomed Inc. (ADVB) vs XWELL, Inc. (XWEL)

Advanced Biomed Inc. and XWELL, Inc. are both Diagnostics & Research companies. XWELL, Inc. is the larger, with a market value of $6.1M against $3.1M — 1.9× the size. XWELL, Inc. has negative trailing earnings, so its P/E is not meaningful; Advanced Biomed Inc. trades at 0.3×. Advanced Biomed Inc. has the higher net margin (0.00% vs −117.8%) and the lower return on invested capital (−33.4% vs 0.00%). Across the 12 metrics below, Advanced Biomed Inc. leads on 10 and XWELL, Inc. on 2.

Valuation

Metric ADVB XWEL Diagnostics & Research median
P/E 0.33 n/m 34.52
P/S n/m 0.17 4.24
P/B 0.20 0.59 3.42
Price to free cash flow n/m n/m 33.51
EV/EBITDA n/m 0.12 23.44
EV/Sales n/m (0.06) 5.18
Earnings yield 300.76% (933.33%) (1.50%)
Free cash flow yield (185.35%) (278.57%) 0.00%

Profitability

Metric ADVB XWEL Diagnostics & Research median
Gross margin — 34.34% 48.32%
Operating margin 0.00% (61.31%) (5.68%)
Net margin 0.00% (117.83%) (4.10%)
Free cash flow margin 0.00% (47.65%) 0.00%
Return on equity 84.77% (557.21%) 0.00%
Return on assets 36.47% (155.10%) (6.05%)
Return on invested capital (33.43%) 0.00% 0.00%

Growth

Metric ADVB XWEL Diagnostics & Research median
Revenue growth (TTM) — (7.58%) 8.99%
EPS growth (last fiscal year) 266.56% (38.80%) 20.36%
Revenue growth, 5-year CAGR — 28.35% 7.30%
Net income growth, 5-year CAGR — 0.00% 0.00%

Health

Metric ADVB XWEL Diagnostics & Research median
Debt to equity 0.00 0.00 0.01
Current ratio 9.33 2.27 2.27
Net debt to EBITDA 0.06 (0.08) 0.68

Dividend

Metric ADVB XWEL Diagnostics & Research median
Dividend yield — — 0.67%
Payout ratio — — 0.20

Size

Metric ADVB XWEL Diagnostics & Research median
Market cap 3.14m 6.08m 2.22b

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack